SterRx recalls 40 mg per 250 mL PHENYLephrine HCl injection due to lack of sterility assurance. This Rx-only medication may cause infections if used.
Lack of Assurance of Sterility
SterRx is recalling a specific prescription injection product because it lacks sterility assurance. Using this product could lead to infections, so affected users should stop using it.
The injection lacks sterility assurance, meaning it could contain harmful bacteria or other contaminants. If used, this could cause infections or other health issues.
Prescription users of this injection product are affected. Those with the specific NDC number 70324-252-01 are most at risk.
Check for the NDC number 70324-252-01 on the product label. This injection is sold by SterRx in New York and was distributed starting in December 2021.
Discard the product immediately as it may cause infections.
No, this product lacks sterility assurance and could cause infections if used.
Look for the NDC number 70324-252-01 on the label. This injection was distributed starting in December 2021.
Discard it immediately as it may cause infections.
We’ve drafted a message you can send SterRx to request your refund or repair — edit it as you like.
Subject: Recall D-0323-2022 — SterRx SterRx Hello, I own a SterRx that is covered by recall D-0323-2022 from SterRx. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
